These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7593500

  • 1. Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
    Balasch J, Fábregues F, Tur R, Creus M, Casamitjana R, Peñarrubia J, Barri PN, Vanrell JA.
    Hum Reprod; 1995 Jun; 10(6):1377-81. PubMed ID: 7593500
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A, David H, Libal Y, Ballas S.
    Harefuah; 1995 Dec 01; 129(11):455-6, 536. PubMed ID: 8846950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2006 Jul 01; 21(7):1894-900. PubMed ID: 16556673
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec 01; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.
    Wu TC.
    J Reprod Med; 2000 Feb 01; 45(2):156-8. PubMed ID: 10710751
    [Abstract] [Full Text] [Related]

  • 17. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2005 Jul 01; 20(7):1798-804. PubMed ID: 15890740
    [Abstract] [Full Text] [Related]

  • 18. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA, Stirling D, Menzies GS, Baird DT.
    Reproduction; 2005 Jan 01; 129(1):61-73. PubMed ID: 15615899
    [Abstract] [Full Text] [Related]

  • 19. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
    Andersen CY, Humaidan P, Ejdrup HB, Bungum L, Grøndahl ML, Westergaard LG.
    Hum Reprod; 2006 Aug 01; 21(8):2126-30. PubMed ID: 16682403
    [Abstract] [Full Text] [Related]

  • 20. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY.
    Hum Reprod; 2005 May 01; 20(5):1213-20. PubMed ID: 15760966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.